Research on Centralized Surveillance of Safety Hospital after Shu Xuening Injection (Xue Le Tong)

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035003

Enrollment

Unknown

Registered

2020-07-27

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse reactions/events

Interventions

Case series:Use Shuxuening Injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All hospitalized patients treated with Shuxuening Injection.

Exclusion criteria

Exclusion criteria: Inpatients who were unable to collect the information needed for this study.

Design outcomes

Primary

Measure	Time frame
ADR/ADE;	—

Countries

China

Contacts

Public ContactLi Xuelin

The First Affiliated Hospital of He'nan University of Chinese Medicine

lixuelin450000@163.com+86 13703711133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026